FEBS Open Bio
Brief Name:
FEBS OPEN BIO
Impact factor:
2.8 (2023)
ISSN:
2211-5463
Open Access:
Yes
Publisher:
Wiley-Blackwell
Article Processing Charge:
$2010 USD/£1240 GBP/€1600 EUR
Annual Articles:
173
Self-citation Rate:
3.6%
Chinese Academy of Sciences SCI Journal Classification:
| Major category | Ｍinor category | TOP journal | Ｒeview journal |
|---|---|---|---|
Q4 BIOLOGICAL |
BIOCHEMISTRY AND MOLECULAR BIOLOGY | No | No |
Subject Classification:
BIOCHEMISTRY & MOLECULAR BIOLOGY
CiteScore:
| CiteScore | SJR | SNIP | CiteScore ranking | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5.1 | 0.789 | 0.56 |
|
H-Index:
26
SCI Index Status:
Science Citation Index Expanded
Official Review Time:
Submission to first decision: 5 days
Submission to acceptance: 100 days
PubMed Central:
Submission Site:
Aims and Scope:
FEBS Open Bio is an open access journal that publishes original research in the fields of biochemistry, biophysics, and cell & molecular biology. All submissions, including descriptive, theoretical, exploratory, and confirmatory studies, are considered provided they make a meaningful contribution to the scientific community and are based on robust methodology, sound ethical standards, and careful interpretation of data.
The journal publishes Research articles, Methods, Hypotheses, Education articles, and Reviews.
The journal publishes Research articles, Methods, Hypotheses, Education articles, and Reviews.
Disclaimer:
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.